Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-19

Clinical Trial Update: Brain Enhancement Training Towards Elders Resilience to Aging, Phase IIB [NA]

View source ↗

Summary

A Phase IIB trial evaluating brain enhancement training for age-related cognitive decline in older adults has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Posit Science Corporation | Conditions: Age-related Cognitive Decline | NA | Status: COMPLETED